19 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
Regulation” means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, and the expression
8-K
EX-1.1
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
Assets Control (“OFAC”), the United Nations Security Council (“UNSC”), the European Union, His Majesty’s Treasury (“HMT”), or other relevant sanctions … with, and since May 25, 2018, has been and currently is in compliance with, the European Union General Data Protection Regulation (“GDPR”) (EU 2016
424B5
rlhemq
17 Jul 23
Prospectus supplement for primary offering
4:49pm
424B5
s7fxy
27 Apr 23
Prospectus supplement for primary offering
7:06am
S-3
8aieew8q7uditiukb
1 Jul 22
Shelf registration
5:06pm
S-3
EX-1.2
zazy wp1ehlt3
1 Jul 22
Shelf registration
5:06pm
10-K
q55374zq9uukbmd6v
28 Mar 22
Annual report
4:51pm
10-Q
50zlssvcf dc907z
16 Aug 21
Quarterly report
4:51pm
424B4
bpm7 fjnek5u
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-1.1
0i9e1 k5l
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
clkkpl2ioufsa
24 Jun 21
IPO registration (amended)
8:17am
S-1
1b7q39 xa0c43gvxy
9 Jun 21
IPO registration
5:02pm
DRS/A
drlw5gelyjzfv
14 May 21
Draft registration statement (amended)
12:00am
DRS/A
EX-4.1
2e7byf
14 May 21
Draft registration statement (amended)
12:00am
DRS
edsw6 q9p58zgv
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next